Indication
Decrease of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
Loading your page…
Loading your page…
Glaucoma, Open-Angle;Ocular Hypertension
Marketing Authorisation Holder: Novartis Europharm Limited
EMA Authorisation: 23/04/2006
INN: travoprost;timolol
AI Drug & Interaction Analysis
Free account required
Ask Osler about DuoTrav: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.